Stool DNA test helps detect precancerous lesions in average-risk CRC population

Using a multitarget stool DNA test helped improve the sensitivity for detecting precancerous colorectal lesions compared with fecal immunochemical tests alone in an average-risk population, according to study results.Gerrit A. Meijer, MD, PhD, of the department of pathology at the Netherlands Cancer Institute, and colleagues wrote that early detection of colorectal cancer and precancerous lesions is critical, and the accuracy of screening tests is an important determining factor in the success of screening programs.“Based on extensive cost-effectiveness evaluation, many organizedRead More

Share on facebook
Share on twitter
Share on linkedin